A proposal for radical changes in the drug-approval process

N Engl J Med. 2006 Aug 10;355(6):618-23. doi: 10.1056/NEJMsb055203.
No abstract available

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Clinical Trials as Topic
  • Drug Approval / economics
  • Drug Approval / methods*
  • Drug Design
  • Drug Evaluation / methods*
  • Humans
  • Mortality / trends
  • Patents as Topic
  • United States / epidemiology
  • United States Food and Drug Administration